Vero Biotech
Latest round
- Series E
Last raised
- Dec 2021
Total raised
- $27M
Investors
- 1
About Vero Biotech
a. Vero Biotech operates as a biotechnology company that focuses on design, development, and commercialization of inhaled nitric oxide (NO) delivery systems for patients with cardiopulmonary conditions. In February 2024, Vero Biotech, Inc. As of July 2024, Brent Furse is the CEO of the company. Vero Biotech provides inhaled nitric oxide delivery systems, focusing on the treatment of persistent pulmonary hypertension in newborns (PPHN). The company’s GENOSYL® Delivery System facilitates the administration of inhaled nitric oxide, which helps dilate pulmonary vasculature and improve oxygenation, reducing the need for extracorporeal membrane oxygenation (ECMO).
Who invested in Vero Biotech
1 investor across 1 round
See all investors in Vero Biotech
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series E
Dec 8, 2021
Amount
$27M
Investors
Questions about Vero Biotech
Who invested in Vero Biotech?
Vero Biotech has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Vero Biotech raised?
Vero Biotech has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Vero Biotech last raise money?
Vero Biotech's most recent round on record is a Series E, in Dec 2021.
What does Vero Biotech do?
Vero Biotech is a biotechnology company.
Where is Vero Biotech headquartered?
Vero Biotech is headquartered in Atlanta, US.
Which VCs invest in companies like Vero Biotech?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Vero Biotech's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series E
Raising like Vero Biotech? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.